Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults
View ORCID ProfileFelicia Cao, Yueling Xiu, Michael Mohnasky, View ORCID ProfileJonathan S. Serody, View ORCID ProfilePaul Armistead, Gianpietro Dotti, View ORCID ProfileMelody Smith, View ORCID ProfileJonathan Huggins, View ORCID ProfileJulia Messina, Bhanu Ramachandran, View ORCID ProfileJennifer Saullo, Joseph Stromberg, Manish K. Saha, Megan Walsh, View ORCID ProfileBarbara Savoldo, View ORCID ProfileNatalie Grover, Heather I. Henderson, View ORCID ProfileTessa M. Andermann
doi: https://doi.org/10.1101/2024.07.10.24310235
Felicia Cao
1Divisions of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Yueling Xiu
2Gillings School of Public Health, University of North Carolina at Chapel Hill, North Carolina, USA
Michael Mohnasky
3School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Jonathan S. Serody
4Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Paul Armistead
4Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Gianpietro Dotti
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
6Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, North Carolina, USA
Melody Smith
7Division of Blood & Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, California, USA
Jonathan Huggins
8Division of Infectious Diseases, Department of Medicine, Duke University, North Carolina, USA
Julia Messina
8Division of Infectious Diseases, Department of Medicine, Duke University, North Carolina, USA
Bhanu Ramachandran
9Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Jennifer Saullo
8Division of Infectious Diseases, Department of Medicine, Duke University, North Carolina, USA
Joseph Stromberg
9Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Manish K. Saha
10Division of Nephrology, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Megan Walsh
3School of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Barbara Savoldo
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
11Division of Hematology-Oncology, Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
Natalie Grover
4Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Heather I. Henderson
9Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA
Tessa M. Andermann
5Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
9Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, North Carolina, USA

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted July 11, 2024.
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults
Felicia Cao, Yueling Xiu, Michael Mohnasky, Jonathan S. Serody, Paul Armistead, Gianpietro Dotti, Melody Smith, Jonathan Huggins, Julia Messina, Bhanu Ramachandran, Jennifer Saullo, Joseph Stromberg, Manish K. Saha, Megan Walsh, Barbara Savoldo, Natalie Grover, Heather I. Henderson, Tessa M. Andermann
medRxiv 2024.07.10.24310235; doi: https://doi.org/10.1101/2024.07.10.24310235
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in Adults
Felicia Cao, Yueling Xiu, Michael Mohnasky, Jonathan S. Serody, Paul Armistead, Gianpietro Dotti, Melody Smith, Jonathan Huggins, Julia Messina, Bhanu Ramachandran, Jennifer Saullo, Joseph Stromberg, Manish K. Saha, Megan Walsh, Barbara Savoldo, Natalie Grover, Heather I. Henderson, Tessa M. Andermann
medRxiv 2024.07.10.24310235; doi: https://doi.org/10.1101/2024.07.10.24310235
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)